TY  - JOUR
AU  - Pauwels, Renske W M
AU  - van der Woude, C Janneke
AU  - Nieboer, Daan
AU  - Steyerberg, Ewout W
AU  - Casanova, María J
AU  - Gisbert, Javier P
AU  - Kennedy, Nick A
AU  - Lees, Charlie W
AU  - Louis, Edouard
AU  - Molnár, Tamás
AU  - Szántó, Kata
AU  - Leo, Eduardo
AU  - Bots, Steven
AU  - Downey, Robert
AU  - Lukas, Milan
AU  - Lin, Wei C
AU  - Amiot, Aurelien
AU  - Lu, Cathy
AU  - Roblin, Xavier
AU  - Farkas, Klaudia
AU  - Seidelin, Jakob B
AU  - Duijvestein, Marjolijn
AU  - D'Haens, Geert R
AU  - de Vries, Annemarie C
AU  - CEASE Study Group
PY  - 2021
DO  - 10.1016/j.cgh.2021.03.037
UR  - http://hdl.handle.net/10668/22082
T2  - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
AB  - Tools for stratification of relapse risk of Crohn's disease (CD) after anti-tumor necrosis factor (TNF) therapy cessation are needed. We aimed to validate a previously developed prediction model from the diSconTinuation in CrOhn's disease patients in...
LA  - en
KW  - Anti-TNF Cessation
KW  - Crohn’s Disease
KW  - Prediction
KW  - Adalimumab
KW  - Crohn Disease
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Infliximab
KW  - Necrosis
KW  - Recurrence
KW  - Retrospective Studies
KW  - Tumor Necrosis Factor Inhibitors
TI  - Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies.
TY  - research article
VL  - 20
ER  -